3:52
unstable clonal plasma cells; genetic changes making them prone to further mutations
MBBS NAIJA
3:09
peripheral and autonomic neuropathies; nerve disorders that affect peripheral nervous system
3:53
spectrum of disease In Plasma cell dyscrasias; abnormal clonal proliferation of plasma cells
2:31
Protein Immunofixation for Plasma Cell Dyscrasia
3:22
Overview And Introduction to Plasma cell dyscrasia; plasma cell proliferative diseases
2:48
Plasma cell leukemia; highly aggressive cancer involving plasma cells
2:45
POEMS syndrome And Castleman disease; Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal
2:18
Primary plasma cell leukemia And Secondary plasma cell leukemia
2:21
primary genomic changes and secondary genomic changes
2:35
Protein Immunofixation Principle; laboratory technique, identify, characterize specific proteins
3:05
Protein Electrophoresis Principle
2:34
Quantitative immunoglobin and Free light chain assays
2:58
Protein Immunofixation; mmunofixation electrophoresis, or IFE; identify and characterize monoclonal
3:13
Solitary plasmacytoma And Extramedullary plasmacytoma
2:32
Smoldering Multiple myeloma; intermediate, asymptomatic stage, in spectrum of plasma cell dyscrasias
2:42
TEMPI syndrome And AESOP syndrome
3:19
V(D)J recombination, Rearrangement; Variable–Diversity–Joining recombination
2:03
plasmacytoma tumors; Localized growths of abnormal plasma cells
3:18
plasma cell disorders or plasma cell proliferative diseases
Protein electrophoresis for monoclonal gammopathy of undetermined significance mgus
2:27
somatic hypermutation; process in adaptive immune system that enhances the ability of B cells
WHO classification of plasma cell Neoplasms - World Health Organization
Toxicities associated with Plasma cell dyscrasia
Abnormal Protein Electrophoresis for Plasma Cell Dyscrasia; monoclonal spike M spike in gamma region
1:56
myeloma protein M Protein; monoclonal protein, hallmark of plasma cell dyscrasias, multiple myeloma
3:57
extensive bleeding tendencies; platelet disorders, coagulation factor deficiencies, or vascular
2:01
non secretory multiple myeloma; malignant plasma cells do not secrete detectable monoclonal proteins
2:51
Myeloma deposits; accumulation of malignant plasma cells or immunoglobulin light chains
2:28
cold induced hemolytic anemia or Cold Agglutinin Disease CAD; exposure to cold temperatures triggers
1:52
clone of plasma cells; group of plasma cells that all originate from a single parent B cell
2:26
Classification of Plasma Cell Dyscrasias Blood Disorders
2:16
Extramedullary Plasmacytoma; type of plasma cell tumor that arises outside bone marrow
2:39
Immunoglobulin Class Switching, Isotype Switching, Class Switch Recombination (CSR)
2:20
Gamma globulins; globulins identified by position in serum protein electrophoresis
light chain myeloma cast nephropathy or myeloma kidney, renal complication of multiple myeloma
Monoclonal Gammopathies; proliferation of a single clone of plasma cells or B lymphocytes
2:24
Chemical Analysis For Plasma Cell Dyscrasia Types and Findings
2:54
light chain proximal tubulopathy; kidney disorder by accumulation of monoclonal immunoglobulin
3:16
Evolution of the clonal plasma cells and myeloma proteins in Dyscrasia
2:36
extracellular amyloid deposits amyloidosis; accumulations of misfolded protein fibrils outside cells
3:30
Gammopathies; disorders characterized by abnormal production of immunoglobulins antibodies
Crow–Fukase Syndrome, Takatsuki disease, PEP syndrome, POEMS syndrome
2:40
Lymphoplasmacytoid cells; immune cells exhibit features intermediate between lymphocytes, plasma
2:47
Normal Serum Protein Electrophoresis
B-cells infiltrating the Bone marrow and Forming Distinct masses in the bone
3:06
Investigations and Laboratory for Plasma Cell Dyscrasias
Objectives and Course outline for Plasma Cell Dyscrasias
3:02
Myeloma protein toxicities; harmful effects caused by the overproduction and accumulation
3:34
Mu Heavy chain Diseasep, Gamma Heavy chain Disease, Alpha Heavy chain Disease
3:46
Biomarkers of Malignancy; substances in the body that indicate cancer
3:07
Biomarkers of malignancy; substances in the body that indicate Cancer
Organized Deposit and Non-organized Deposit Glomerulonephritis Disease
3:01
Osteolytic lesions; areas of bone damage where normal bone tissue is destroyed or resorbed
